Lumenis
- Company typePrivate
- Founded1966
- HeadquartersJerusalem, Israel
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Lumenis firmographics
Firmographics- Name
- Lumenis
- Legal name
- Lumenis Be Ltd.
- Website
- https://lumenis.com
- Company type
- Private
- Founded year
- 1966
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Lumenis industry classification
Industry- Product category
- Energy-based medical devices (Aesthetic and Vision)
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Laser & Energy-Based Dermatology (HLAKACAF)
- akta.pro secondary industry
- Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)
Keywords
Where Lumenis is headquartered
LocationHeadquarters
- HQ city
- Jerusalem
- HQ country
- Israel
- HQ region
- Middle East
Offices5 records
Markets served
Lumenis business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Aesthetic Devices: Sale of capital equipment platforms (Stellar M22, triLift, SPLENDOR X, LightSheer QUATTRO, UltraPulse, FoLix) and consumables/accessories to aesthetic practitioners including dermatologists, plastic surgeons, and medspas
- Ophthalmology/Vision Devices: Sale of laser systems for dry eye treatment (OptiLIGHT, OptiPLUS, OptiLIFT), glaucoma management (Digital Duet, Digital Trio, Selecta Duet/Trio), and retinal photocoagulation to eye care professionals
- Service and Support: Aftermarket service, training, and support services for installed device base
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Lumenis product offering
Product offeringCore offering
Lumenis develops, manufactures, and commercializes energy-based medical devices using laser, Intense Pulsed Light (IPL), and radio-frequency (RF) technologies for the Aesthetic and Vision markets. The company sells capital equipment platforms (e.g., Stellar M22, triLift, FoLix, SPLENDOR X, ULTRApulse Alpha, OptiLIGHT) along with consumables, training, and aftermarket service to hospitals, dermatologists, plastic surgeons, ophthalmologists, medspas, and hair restoration practices across 88+ countries.
Product overview
Lumenis offers a comprehensive portfolio of energy-based medical devices for the Aesthetic and Vision markets. The Aesthetic portfolio includes platforms for facial muscle stimulation (triLift), hair removal (SPLENDOR X, LightSheer QUATTRO), skin resurfacing (ULTRApulse Alpha, AcuPulse), hair loss treatment (FoLix), skin rejuvenation (Stellar M22, M22), body treatments (NuEra Tight, Legend Pro+), and women's health (FemTouch). The Vision portfolio addresses dry eye (OptiLIGHT, OptiLIFT, OptiPLUS), glaucoma (Digital Duet, Digital Trio, Smart Selecta Duet/Trio), and retina (Smart532, Vision One, Array LaserLink, LumeProbe). The products utilize core technologies including CO2 and diode lasers, IPL (Intense Pulsed Light), Nd:YAG, radiofrequency (RF), and dynamic muscle stimulation. These are primarily modular platform systems with multiple handpieces and treatment modes, sold to hospitals, aesthetic clinics, and ophthalmology practices worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- Pollogen: Consumer aesthetic devices and technologies for at-home use
- FoLix
- triLift
- Stellar M22
- OptiLIGHT
- OptiLIFT
- OptiPLUS
- SPLENDOR X
- ULTRApulse Alpha
- Legend Pro+
- LightSheer
- NuEra Tight
- M22
- AcuPulse
- FemTouch
Products and services
- FoLix FDA-cleared non-ablative fractional laser device for hair loss treatment that uses precise pulses of laser light to stimulate hair follicles in adult males and females with Fitzpatrick skin types I-IV. Targeted at hair restoration practices and aesthetic clinics.
- triLift
- Stellar M22 Multi-application aesthetic platform with XPL (Expert Pulsed Light) technology integrating four advanced technologies for treating over 30 skin and hair indications across all skin types. Sold to dermatologists, plastic surgeons, and aesthetic clinics.
- SPLENDOR X Laser hair removal platform combining Alexandrite and Nd:YAG lasers powered by BLEND X technology for effective hair removal across all skin types. Sold to aesthetic clinics, medspas, and dermatology practices.
- ULTRApulse Alpha
- Legend Pro+ RF treatment platform combining TriPollar RF, DMA muscle stimulation, and TriFractional technology for skin tightening and body treatments. Sold to aesthetic clinics and medspas.
- LightSheer QUATTRO Diode laser hair removal system offering 805nm and 1060nm wavelengths with High Speed Vacuum assisted technology and ChillTip Integrated Contact Cooling for all skin types. Sold to aesthetic practices and medspas.
- NuEra Tight Temperature-controlled RF technology platform for skin tightening, body contouring, and cellulite treatment using proprietary RF energy delivery. Sold to aesthetic clinics, medspas, and body contouring practices.
- OptiLIGHT IPL-based dry eye treatment device that addresses the root cause of evaporative dry eye disease through targeted light therapy on the periorbital area. Sold to ophthalmologists and eye care practices.
- OptiLIFT Non-surgical dynamic muscle stimulation device for the periorbital area that tones muscles to address droopy eyelids and impaired blinking, with Health Canada approval. Sold to ophthalmologists and eye care practices.
- OptiPLUS Dual-frequency RF technology device that complements OptiLIGHT's dry eye solution by providing additional therapeutic benefits. Sold to ophthalmologists and eye care practices.
- Digital Duet All-in-one digital platform combining SLT and YAG lasers for glaucoma therapy and posterior capsule opacification (PCO) treatment. Sold to ophthalmologists.
- Digital Trio 3-in-1 digital platform combining SLT, YAG, and retina care capabilities for comprehensive glaucoma and retina treatment. Sold to ophthalmology practices.
- Smart532 Green photocoagulator with SmartPulse sub-threshold technology for retinal treatments with optimized energy delivery. Sold to ophthalmologists and retinal specialists.
- Vision One Multi-wavelength photocoagulator offering green, yellow, and red wavelengths for versatile retinal treatment options. Sold to ophthalmologists and retinal specialists.
- Array LaserLink Pattern scanning laser technology for retinal photocoagulation with enhanced precision and efficiency. Sold to ophthalmologists and retinal specialists.
- LumeProbe Premium ophthalmic endophotocoagulation laser probes for retinal procedures, available in straight, curved, illuminated, and aspirating types in 20, 23, and 25 gauge sizes. Sold to ophthalmic surgeons.
- Smart Selecta Duet SLT and YAG photodisruptor combination platform for glaucoma care in one compact system. Sold to ophthalmologists.
- Smart Selecta Trio Comprehensive platform combining SLT, YAG, and Smart532 for retinal, cataract, and glaucoma therapy. Sold to ophthalmology practices.
- Novus Spectra Green dual-port photocoagulator for operating room and clinic use in retinal treatments. Sold to ophthalmologists and hospitals.
- M22 Aesthetic platform for IPL and laser treatments including skin rejuvenation, pigmentation, vascular lesions, and hair removal. Sold to dermatology and aesthetic practices.
- AcuPulse CO2 laser system for aesthetic and surgical applications including skin resurfacing, with variants for women's health. Sold to hospitals, plastic surgeons, and dermatology practices.
- FemTouch CO2 laser-based vaginal health treatment for women's health indications including vaginal atrophy and stress urinary incontinence. Sold to OB/GYN practices, urogynecologists, and women's health clinics.
Quantifiable outcome
- 76-100% clearance of vascular and pigmented lesions after a single XPL session on Stellar M22
- +4 more outcomes
Companies that use Lumenis
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles5 records
Lumenis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Lumenis partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, flagship and minor.
- BosleycoreBosley, the largest hair restoration practice in the United States, became the first national hair restoration medical practice to offer FoLix FDA-cleared fractional laser for hair loss treatment. Partnership initiated September 2024 at Beverly Hills location with plans to expand nationwide.
- Harrods Wellness ClinicflagshipPremium London wellness clinic partnership establishing excellence positioning for Lumenis aesthetic treatments in luxury retail healthcare setting.
- Brad Oliver, President of Lumenis AmericascoreExecutive leadership driving Americas expansion and partnership development for FoLix and other product launches in North American market.
- Street ChildminorLumenis Cares Foundation supports Street Child charity focusing on children's education and protection in underserved communities globally.
- Right-to-SightminorNon-profit organization at Royal College of Surgeons Ireland working with Lumenis to eliminate preventable blindness in Africa through SLT glaucoma treatment technology.
- Aravind Eye Care SystemminorSocial organization in India committed to eliminating needless blindness, collaborating with Lumenis on Selective Laser Trabeculoplasty research to minimize glaucoma progression.
- Wellman Center for Photomedicine (Harvard Medical School)minorDr. Rox Anderson-led center collaborating on burn treatment missions using Lumenis UltraPulse laser technology in Russia, China, Vietnam, and Armenia.
- Wills Eye InstituteminorLeading U.S. eye hospital partnering with Lumenis to provide SLT procedures to underserved patients in Philadelphia.
- St. Luke Foundation for HaitiminorHumanitarian medical mission partnership providing BPH treatment using VersaPulse PowerSuite holmium laser technology with Dr. Mitchell Humphreys of Mayo Clinic.
- Wounded Warriors ProjectminorLumenis HOPE campaign helping wounded U.S. soldiers access advanced burn treatment with UltraPulse SCAAR FX CO2 laser regardless of ability to pay.
Scale indicators12 records
Recent moves7 records
Expansion highlights5 records
Lumenis competitors and assessment
Company assessmentDirect peers
- Alma Lasers: Alma Lasers is a leading competitor in aesthetic lasers, IPL, RF, and ultrasound platforms for hair removal, skin resurfacing, and body treatments — competing head-to-head with Lumenis across multiple product categories and geographies.
- Cutera: Cutera is a direct competitor offering laser and energy-based aesthetic platforms including AviClear (acne), excel V (vascular), and truSculpt (body contouring) — competing in overlapping indications with Lumenis' Stellar M22 and body platforms.
- Cynosure (Hologic): Cynosure is a direct competitor in energy-based aesthetic devices (lasers, IPL, RF) for hair removal, skin rejuvenation, and body contouring serving dermatology and medspa customers globally — directly overlapping with Lumenis' Stellar M22, SPLENDOR X, and triLift platforms.
- InMode: InMode develops RF-based aesthetic platforms (Morpheus8, Evolve, BodyTite) for body contouring and skin remodeling — overlapping with Lumenis' Legend Pro+, NuEra Tight, and RF micro-needling offerings.
- BTL Industries: BTL Industries competes with Lumenis in non-invasive body contouring, skin tightening, and muscle stimulation (EMSCULPT, EMSELLA) — directly comparable to triLift/Body platforms and NuEra Tight.
- Sciton: Sciton is a privately held direct competitor offering aesthetic laser and light platforms (BBL, Halo, MOXI, Profractional) — closely comparable to Lumenis' skin rejuvenation and resurfacing devices.
- Candela Corporation: Candela (formerly Syneron-Candela) is a direct competitor offering aesthetic and medical laser systems for hair removal, skin treatments, and women's health — directly comparable to Lumenis' aesthetic platform portfolio.
- Iridex Corporation: Iridex is a direct competitor in ophthalmic laser systems for glaucoma and retinal treatments — comparable to Lumenis' Digital Duet, Smart Selecta, and photocoagulator vision portfolio.
- Solta Medical (Bausch Health): Solta Medical offers the Thermage, Fraxel, Clear+Brilliant, and Vaser platforms for skin tightening, resurfacing, and body contouring — overlapping directly with Lumenis' ULTRApulse Alpha and skin rejuvenation portfolio.
Broad incumbents
- AbbVie (Allergan Aesthetics): AbbVie/Allergan Aesthetics is a broad incumbent in medical aesthetics (Botox, CoolSculpting, SkinMedica) — operating in adjacent categories to Lumenis and competing for the same dermatology and medspa customer wallet, though not in laser/IPL/RF devices.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Lumenis social profiles
Digital presenceLumenis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lumenis leadership team
Management profileNumber of profiles
Profiles13 records
Lumenis subsidiaries and ownership
Company hierarchySubsidiaries2 records
Lumenis funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lumenis M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lumenis
What does Lumenis do?
Lumenis develops, manufactures, and commercializes energy-based medical devices using laser, Intense Pulsed Light (IPL), and radio-frequency (RF) technologies for the Aesthetic and Vision markets. The company sells capital equipment platforms (e.g., Stellar M22, triLift, FoLix, SPLENDOR X, ULTRApulse Alpha, OptiLIGHT) along with consumables, training, and aftermarket service to hospitals, dermatologists, plastic surgeons, ophthalmologists, medspas, and hair restoration practices across 88+ countries.
Is Lumenis a public or private company?
Lumenis is a private company. It is classified as private equity controlled and is currently operating.
When was Lumenis founded?
Lumenis was founded in 1966. It employs 1,001 to 5,000 people.
Where is Lumenis based?
Lumenis is headquartered in Jerusalem, Israel, in the Middle East region.
How does Lumenis make money?
Three revenue lines are on record. Medical Aesthetic Devices are the primary driver. The others are ophthalmology/Vision Devices and service and Support.
Who are Lumenis's main competitors?
Direct peers on record are Alma Lasers, Cutera, Cynosure (Hologic), InMode, BTL Industries, Sciton, Candela Corporation, Iridex Corporation and Solta Medical (Bausch Health). AbbVie (Allergan Aesthetics) is listed as a broad incumbent.
Does Lumenis have an API?
No public API is recorded for Lumenis.
What industry is Lumenis in?
Lumenis's product category is Energy-based medical devices (Aesthetic and Vision). Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology, with a secondary code of HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser). Its NAICS code is 334510 and its SIC code is 3845.